OrthoPediatrics (NASDAQ:KIDS) CFO Buys $98,525.16 in Stock

Key Points

• OrthoPediatrics CFO Fred Hite purchased 5,076 shares of the company's stock for a total of $98,525.16, increasing his holdings by 2.44% to 213,065 shares.
• The company's stock is currently trading at $20.71, with a market capitalization of $519.28 million and a 1-year price range between $16.59 and $33.14.
• OrthoPediatrics recently reported an earnings loss of ($0.11) per share, surpassing analyst estimates, while setting guidance for a projected EPS of -0.93 for the current fiscal year.

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) CFO Fred Hite acquired 5,076 shares of OrthoPediatrics stock in a transaction dated Thursday, August 21st. The shares were acquired at an average price of $19.41 per share, with a total value of $98,525.16. Following the completion of the acquisition, the chief financial officer directly owned 213,065 shares of the company's stock, valued at approximately $4,135,591.65. The trade was a 2.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

OrthoPediatrics Stock Down 0.4%

OrthoPediatrics stock traded down $0.08 during trading on Friday, hitting $21.36. 89,596 shares of the company were exchanged, compared to its average volume of 181,395. The company has a market capitalization of $535.50 million, a P/E ratio of -11.93 and a beta of 1.12. The business's 50 day moving average is $21.13 and its 200 day moving average is $22.14. OrthoPediatrics Corp. has a 52 week low of $16.59 and a 52 week high of $33.14. The company has a current ratio of 6.66, a quick ratio of 3.43 and a debt-to-equity ratio of 0.27.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.17) by $0.06. The firm had revenue of $61.08 million for the quarter, compared to the consensus estimate of $61.40 million. OrthoPediatrics had a negative net margin of 18.92% and a negative return on equity of 6.36%. OrthoPediatrics has set its FY 2025 guidance at EPS. Analysts predict that OrthoPediatrics Corp. will post -0.93 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on KIDS. Needham & Company LLC restated a "buy" rating and issued a $42.00 target price on shares of OrthoPediatrics in a research note on Thursday, May 8th. BTIG Research dropped their price target on OrthoPediatrics from $40.00 to $39.00 and set a "buy" rating on the stock in a report on Wednesday, August 6th. Citigroup restated a "market outperform" rating on shares of OrthoPediatrics in a research note on Friday, August 8th. Wall Street Zen raised OrthoPediatrics from a "sell" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, JMP Securities set a $35.00 price target on shares of OrthoPediatrics and gave the company a "market outperform" rating in a research report on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $34.14.

Hedge Funds Weigh In On OrthoPediatrics

Several hedge funds have recently made changes to their positions in KIDS. Millennium Management LLC purchased a new stake in OrthoPediatrics in the fourth quarter worth $9,798,000. Point72 Asset Management L.P. bought a new stake in OrthoPediatrics during the fourth quarter worth about $7,450,000. Harbor Capital Advisors Inc. grew its holdings in OrthoPediatrics by 116.5% in the second quarter. Harbor Capital Advisors Inc. now owns 333,959 shares of the company's stock worth $7,173,000 after purchasing an additional 179,733 shares during the period. Wellington Management Group LLP increased its stake in shares of OrthoPediatrics by 20.2% during the fourth quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company's stock valued at $24,601,000 after purchasing an additional 178,078 shares in the last quarter. Finally, Paradigm Capital Management Inc. NY boosted its position in shares of OrthoPediatrics by 1,607.0% in the 1st quarter. Paradigm Capital Management Inc. NY now owns 170,700 shares of the company's stock worth $4,204,000 after purchasing an additional 160,700 shares in the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.